60 items

Four in 10 US Adults Are at High Risk for Vision Loss

March 12, 2020

In 2017, approximately 93 million US adults aged 18 years or older, or about 4 in 10, were at high risk for vision loss, according to a new study published in JAMA Ophthalmology.
A fundus image shows an eye with aggressive posterior retinopathy of prematurity (AP-ROP). The i-ROP DL deep learning system quantified the dilation and tortuosity of the retinal vessels, which both occur to a high degree in AP-ROP.

AI may help spot newborns at risk for most severe form of blinding disease

March 4, 2020

An artificial intelligence (AI) device that has been fast-tracked for approval by the Food and Drug Administration may help identify newborns at risk for aggressive posterior retinopathy of prematurity (AP-ROP). AP-ROP is the most severe form of ROP.
Patient undergoes and eye exam. Courtesy National Eye Institute.

For Aging Patients, One Missed Doctor’s Visit Can Lead to Vision Loss

February 6, 2020

Missing a single ophthalmology appointment over a two-year period was associated with decreased visual acuity for patients with macular degeneration according to a new Penn Medicine study.
Man reading a book

Reward improves visual perceptual learning — but only after people sleep

January 17, 2020

A new study from Brown researchers finds that rewards improve performance on a visual perceptual task only if participants sleep after training.
Blood cells are converted into induced pluripotent stem cells, which are them made into retinal pigment epithelial cells (RPE).

NIH launches first U.S. clinical trial of patient-derived stem cell therapy to replace and repair dying cells in retina

December 16, 2019

Researchers at the National Eye Institute (NEI) are launching a clinical trial to test the safety of a novel patient-specific stem cell-based therapy to treat geographic atrophy, the advanced “dry” form of age-related macular degeneration.
Girl reading book, with hand over one eye

Treatment for common vision disorder does not improve children’s reading skills

October 23, 2019

Results from a clinical trial funded by the National Eye Institute (NEI) show that while vision therapy can successfully treat convergence insufficiency (CI) in children, it fails to improve their reading test scores.
Grantee News

Antibody-based eye drops show promise for treating dry eye disease

October 11, 2019

Researchers at the University of Illinois at Chicago are the first to identify the presence of a specific type of antibody, called anti-citrullinated protein autoantibodies, or ACPAs, in human tear fluid.
glasses

Study Looks to Measure Benefits of Eyeglasses for Toddlers

October 8, 2019

A team of University of Arizona researchers has received a five-year, $4.1 million grant to study whether using eyeglasses to correct astigmatism in toddlers improves language, cognitive and motor development.
Grantee News

Opioid prescriptions filled after eye surgery doubled from 2000 to 2014

September 19, 2019

A study from the University of Pennsylvania suggests efforts in the past decade to reduce the invasiveness and recovery time for ocular procedures have not impacted opioid use.
Uveitis is inflammation of the eye originating in the uvea, which includes the iris, ciliary body, and the choroid. Anterior uveitis affects the iris; intermediate uveitis affects the ciliary body, posterior uveitis affects the choroid, and panuveitis affects multiple areas of the uvea.

Two commonly used uveitis drugs perform similarly in NIH-funded clinical trial

September 10, 2019

Methotrexate and the more expensive mycophenolate mofetil performed similarly in a head-to-head clinical trial that compared the two drugs for treating noninfectious uveitis, an eye disease that accounts for up to 15% of blindness in the U. S.